Home/Filings/4/0001683168-18-000493
4//SEC Filing

Semechkin Andrey 4

Accession 0001683168-18-000493

CIK 0001355790other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 3:34 PM ET

Size

10.8 KB

Accession

0001683168-18-000493

Insider Transaction Report

Form 4
Period: 2018-02-20
Semechkin Andrei
DirectorChief Executive Officer10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2018-02-20$1.09/sh+30,556$33,3063,419,816 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2018-02-2015,55654,444 total
    Exercise: $1.10Exp: 2027-05-31Common Stock (54,444 underlying)
  • Exercise/Conversion

    Common Stock

    2018-02-20$1.10/sh+15,556$17,1123,435,372 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2018-02-2030,55669,444 total
    Exercise: $1.09Exp: 2027-02-10Common Stock (69,444 underlying)
Footnotes (2)
  • [F1]3/36th of the shares underlying such options shall vest on May 10, 2017, and the remaining share in equal monthly installments over a period of 33 months.
  • [F2]3/36th of the shares underlying such options shall vest on August 31, 2017, and the remaining share in equal monthly installments over a period of 33 months.

Issuer

International Stem Cell CORP

CIK 0001355790

Entity typeother

Related Parties

1
  • filerCIK 0001447708

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 3:34 PM ET
Size
10.8 KB